HAPV3
ONconsolidatedHAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.
CNPJ 05197443000138
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| JRS CAP PROPRIO | 2021-12-22 | 2021-12-27 | 0.005373 |
| JRS CAP PROPRIO | 2021-09-22 | 2021-09-27 | 0.011765 |
| JRS CAP PROPRIO | 2021-06-30 | 2021-07-06 | 0.017684 |
| DIVIDENDO | 2021-04-30 | 2021-05-05 | 0.002526 |
| JRS CAP PROPRIO | 2020-12-30 | 2021-01-07 | 0.025131 |
| JRS CAP PROPRIO | 2020-09-03 | 2020-09-10 | 0.149087 |
| DIVIDENDO | 2020-04-28 | 2020-04-28 | 0.016484 |
| JRS CAP PROPRIO | 2019-12-27 | 2020-01-03 | 0.159688 |
| JRS CAP PROPRIO | 2019-06-27 | 2019-07-02 | 0.155361 |
| DIVIDENDO | 2019-04-22 | 2019-04-22 | 0.121653 |
| JRS CAP PROPRIO | 2018-12-11 | 2018-12-14 | 0.184322 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 31.58bn | -142.17m | 11.8% | -0.5% | -0.3% | -0.2% | 0.44 | 14.73 | — | — |
| 2024 | 28.91bn | -649.38m | 11.4% | -2.3% | -1.3% | -0.9% | 0.39 | 2.23 | — | — |
| 2023 | 27.77bn | -757.41m | 11.0% | -2.7% | -1.5% | -1.0% | 0.38 | 4.45 | — | — |
| 2022 | 23.75bn | -775.84m | 23.8% | -3.3% | -1.6% | -1.1% | 0.32 | 5.08 | — | — |
| 2021 | 9.88bn | 500.34m | 31.0% | 5.1% | 4.7% | 2.4% | 0.47 | 10.38 | 79.85 | 0.6% |
| 2020 | 8.55bn | 785.30m | 39.1% | 9.2% | 10.0% | 5.8% | 0.63 | 15.26 | 72.67 | — |
| 2019 | 5.63bn | 851.85m | 39.7% | 15.1% | 11.7% | 6.8% | 0.45 | 63.90 | 52.81 | 0.4% |
| 2018 | 4.58bn | 788.33m | 39.8% | 17.2% | 21.9% | 16.2% | 0.94 | 31.20 | 25.16 | 0.6% |
| 2017 | 3.85bn | 650.60m | 41.8% | 16.9% | 137.8% | 24.9% | 1.47 | — | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 1.22bn | 369.54m | -75.83m | -6.2% |
| Q1 26 | 1.39bn | 534.30m | -100.70m | -7.2% |
| Q4 25 | 7.89bn | 289.21m | -83.66m | -1.1% |
| Q3 25 | 7.92bn | 351.15m | 87.11m | 1.1% |
| Q2 25 | 862.76m | 145.25m | -331.51m | -38.4% |
| Q1 25 | 1.47bn | 671.02m | 185.90m | 12.7% |
| Q4 24 | 7.41bn | 302.35m | -252.35m | -3.4% |
| Q3 24 | 7.73bn | 253.07m | -81.47m | -1.1% |
| Q2 24 | 437.10m | -313.41m | -380.72m | -87.1% |
| Q1 24 | 1.32bn | 498.97m | 59.19m | 4.5% |
| Q4 23 | 24.36bn | 669.80m | -134.80m | -0.6% |
| Q3 23 | 1.21bn | 319.60m | -98.19m | -8.1% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 72.80bn | 48.06bn | 1.51 | 1.83 |
| Q1 26 | 72.99bn | 48.15bn | 1.52 | 1.79 |
| Q4 25 | 72.29bn | 48.25bn | 1.50 | 1.90 |
| Q3 25 | 74.47bn | 48.65bn | 1.53 | 1.98 |
| Q2 25 | 74.35bn | 48.58bn | 1.53 | 2.05 |
| Q1 25 | 74.22bn | 48.87bn | 1.52 | 2.10 |
| Q4 24 | 73.50bn | 48.68bn | 1.51 | 2.11 |
| Q3 24 | 73.87bn | 48.69bn | 1.52 | 1.39 |
| Q2 24 | 74.20bn | 48.76bn | 1.52 | 1.39 |
| Q1 24 | 72.78bn | 49.18bn | 1.48 | 1.41 |
| Q4 23 | 73.19bn | 49.26bn | 1.49 | 1.38 |
| Q3 23 | 72.89bn | 49.39bn | 1.48 | 1.06 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-12 | 43 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-11 | 41 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-18 | 77 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-12 | 43 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-13 | 44 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-12 | 42 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-19 | 78 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-12 | 43 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-08 | 39 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-13 | 43 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-28 | 88 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-08 | 39 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-09 | 40 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-15 | 45 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-02-28 | 59 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-09 | 40 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.